孟德尔随机化
肺癌
共域化
计算生物学
基因组
生物
全基因组关联研究
医学
生物信息学
遗传学
癌症研究
单核苷酸多态性
基因
肿瘤科
分子生物学
基因型
遗传变异
作者
Yi Luan,Xian Ding,Changwen Zhao,Qing Xin,Hua He,Kaixuan Zheng,Wenjun Song,Taijiao Jiang,Wenjian Wang,Chaohui Duan
标识
DOI:10.3389/fphar.2024.1441233
摘要
Background Lung cancer, categorized into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), remains a significant global health challenge. The development of drug resistance and the heterogeneity of the disease necessitate the identification of novel therapeutic targets to improve patient outcomes. Methods We conducted a genome-wide Mendelian randomization (MR) and colocalization analysis using a comprehensive dataset of 4,302 druggable genes and cis-expressed quantitative trait loci (cis-eQTLs) from 31,884 blood samples. The study integrated genomic analysis with eQTL data to identify key genes associated with lung cancer risk. Results The analysis revealed five actionable therapeutic targets for NSCLC, including LTB4R, LTBP4, MPI, PSMA4, and TCN2. Notably, PSMA4 demonstrated a strong association with both NSCLC and SCLC risks, with odds ratios of 3.168 and 3.183, respectively. Colocalization analysis indicated a shared genetic etiology between these gene expressions and lung cancer risk. Conclusion Our findings contribute to precision medicine by identifying druggable targets that may be exploited for subtype-specific lung cancer therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI